August 22, 2016
Galderma Laboratories L.P. and Nestle Skin Health S.A. filed a patent infringement suit in Delaware federal court Friday against Perrigo's U.S. and British affiliates new drug application, saying the company's planned generic version of the Mirvaso gel that treats rosacea violates six patents.